CClinicalTrials.gg
CompletedNCT05462808Updated Jul 18, 2022

ART Restorations With High-viscosity Glass-ionomer Cement Versus Hall Technique in Primary Molars

A Phase 2 interventional study of High viscosity glass ionomer cement and Stainless steel crown in Primary Teeth Retained, sponsored by Esra Oz. Completed at 1 site in Turkey. Open to participants aged 5 Years to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-18.

Sponsored by Esra Oz · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 3 months after the study started (first participant enrolled Mar 2019, registered Jul 2022).
Phase
Phase 2
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
5 Years to 7 Years
Sex
All
01

Study summary

Primary molars are the teeth with the highest caries tendency among primary teeth due to their anatomical features such as wide and flat interface areas. However, some difficulties are encountered during the removal of caries due to the structural features of primary molars and the young age of the child. Therefore, in the treatment of primary molars, Atraumatic Restorative Treatment (ART), in which the soft parts of the carious lesion are cleaned with the help of a sharp hand tool and restored with an adhesive glass ionomer cement (GIC) that releases fluoride, in the following years, the deciduous teeth were removed with a minimally invasive approach. Hall technique, in which a stainless steel crown (SSC) is placed without preparation for treatment, has come to the fore.

Read the detailed description

Many restorative materials, especially GIC, have been used for ART procedures, and with the advancing technology, high-viscosity glass ionomer cements with improved mechanical and chemical properties have emerged. In recent years, zinc-added HVGICs and nano-filled resin-modified HVGICs have been introduced.

The Hall Technique has been suggested in the treatment of asymptomatic decayed primary molars in anxious and fearful patients to ensure patient cooperation. In this technique, it is aimed to stop the progression of caries by covering the carious deciduous molars with SSC and cutting their relationship with the oral environment, without the need for local anesthesia and tooth preparation. Thus, as the bacteria cannot use the carbohydrates in the oral environment, the number of bacteria in the environment will also decrease.

02

Conditions studied

  • Primary Teeth Retained
03

In context

Lead sponsor

This is the only study on the registry with Esra Oz as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • children with no systemic disease,
  • children who had a Frankl Behavioral Scale score 2,
  • children who have no occlusal problems or bad habits,
  • children presenting between 2-5 caries lesion in primary molars.

Exclusion criteria

Exclusion Criteria:

  • teeth with presence of radyolusens in furcation and/or periradicular areas,
  • teeth with pathologic resorption and internal/external resorption
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Atraumatic Restorative Treatment restorations with high-viscosity glass ionomer cement

    Under cotton roll isolation, teeth were restored with EQUIA Forte cement. A layer of EQUIA Forte Coat was applied with a microbrush on surface and then light cured for 20 s

    Drug: High viscosity glass ionomer cement

  • Experimental
    restorations with Hall technique

    In the Hall technique group, the deposits on the occlusal surface of the teeth were gently removed, SSC (3M ESPE, St. Paul, USA) was placed and were cemented using GIC. The crown was pressed tightly.

    Device: Stainless steel crown

Interventions

  • DrugHigh viscosity glass ionomer cement

    High viscosity glass ionomer cement

    Also known as: EQUIA Forte (GC Corp., Leuven, BE)

  • DeviceStainless steel crown

    Stainless steel crown

    Also known as: 3M ESPE, St. Paul, USA

06

What researchers measure

Primary outcomes

  1. Hall technique

    The restorations were scored as Alpha (A), clinically ideal restoration ''successful''; Bravo (B), clinically ''acceptable''; Charlie (C), clinically unacceptable restoration ''unsuccessful''. Outcomes criteria for assessment of the Hall Technique were made according to Innes et al.

    Time frame: up to 18 months

Secondary outcomes

  1. Atraumatic restorative treatment

    Clinical evaluations of teeth treated with ART using EQUIA Forte were performed according to the modified USPHS criteria established by a modification of the United States Public Health Service (USPHS) clinical evaluation criteria.

    Time frame: up to 18 months

07

Study locations

1 site
  • Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department
    Isparta, 32260, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05462808
Lead sponsor
Esra Oz
Responsible party
Esra Oz (Pediatric department, Suleyman Demirel University) — Sponsor-investigator
First posted
Jul 18, 2022
Start date
Mar 20, 2019
Primary completion
Apr 1, 2019
Completion
Apr 1, 2021
Last update
Jul 18, 2022

Study contacts

Esra Oz
study director · Suleyman Demirel University Pediatric Dentistry

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion